Signaling Pathways
-
BA2273 QuipazineSummary: Quipazine is an agonist. -
BA2274 TH1217Summary: TH1217 (ZINC1775962367) is a potent and selective inhibitor. - BA2275 CichoriinSummary: Cichoriin is significantly active for.
- BA2276 ONO-5334Summary: ONO-5334 is a potent, selective and orally active tissue proteinase K inhibitor.
- BA2277 XR8-89Summary: XR8-89 is a potent papain-like inhibitor.
- BA2278 rel-ZotatifinSummary: re-Zotatifin is a racemic isomer of Zotatifin and is less active than Zotatifin as an eIF4A inhibitor.
- BA2279 X77Summary: X77 is a potent non-covalent bond inhibitor of the SARS-CoV-2 protease.
- BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor.
- BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
- BA2282 YH-53Summary: YH-53 is a potent inhibitor.